The Juvenile Diabetes Research Foundation (JDRF) and Amylin Pharmaceuticals, Inc. have agreed to to provide financial support for a clinical proof-of-concept study to investigate the effects of metreleptin, an analog of the human hormone leptin, in patients with type 1 diabetes which will be conducted at The University of Texas (UT) Southwestern Medical Center...
This dish is named after the Italian fishing port Livorno, site of one of the annual spring tuna harvests, and the recipe's not carved in stone tablets anywhere: a quick Google session will reveal that there is a wide range of interpretations being presented as "Tuna Livornese."
MannKind Corporation representatives at the 10th annual meeting of the Diabetes Technology Society unveiled new data on its drug delivery, device and particle technologies demonstrating the bioequivalence, ease of use and efficiency of the company's novel platform. The company presented four studies evaluating...
San Diego based Santarus, a biopharmaceutical company, announced the commercial U.S. launch of CYCLOSET (bromocriptine mesylate) tablets. CYCLOSET is a FDA approved prescription drug to improve glycemic control in adults with type 2 diabetes mellitus both as monotherapy and in combination with other oral antidiabetic agents...
Scientists from Biodel Inc. reported new findings from the company's Linjeta™, insulin glargine, "smart" basal insulin and stabilized glucagon development programs in poster presentations at the Tenth Annual Diabetes Technology Meeting in Bethesda, MD...
The Bristol-Myers Squibb Foundation announced the Together on Diabetes initiative, the largest corporate philanthropic commitment to fighting type 2 diabetes in the United States to date. The $100 million, five year initiative aims to help patients living with type 2 diabetes better manage their disease beyond the doors of their doctor’s office.
Together on Diabetes is the Foundation’s first large-scale diabetes initiative. Working with a wide variety of...
A panel of experts convened by the FDA and NIH to try to advance research and development of the artificial pancreas put forth clinical recommendations to ensure the safe and effective testing of artificial pancreas technology in real-life situations.
The experts are in agreement that even with the advanced treatments available today...
A new study has found that keeping babies off cow's milk may help prevent the development of type 1 diabetes in children. The study followed 230 Finnish babies who received formula because breast milk was not available. Half of the babies received standard cow's milk formula...
Recipe courtesy of Sweet Amandine for Diabetes Awareness Month